Literature DB >> 15696842

Early experience in robot-assisted laparoscopic Heller myotomy.

J P Ruurda1, H G Gooszen, I A M J Broeders.   

Abstract

Heller myotomy for achalasia is routinely performed laparoscopically. This offers patients significant benefits compared to open surgery. Surgeons, however, are limited in their manipulation and visualization during laparoscopic interventions. Robotic telemanipulation systems were introduced with the objective of alleviating these limitations. The purpose of this study was to demonstrate the efficacy and safety of performing a Heller myotomy with the use of a robotic telemanipulation system. Fourteen patients were operated on with the da Vinci robot system. Robotic system set-up time, per- and postoperative complications, blood loss, operating time and hospital stay were recorded. Follow-up included manometry and symptom score. The robotic system set-up time was 15 min (10-15). Thirteen procedures (13/14: 93%) were completed by laparoscopic surgery. One procedure was converted because of inadequate exposure. One peroperative mucosal perforation was closed laparoscopically. The median blood loss was 10 mL (10-200). Median operating time was 90 min (75-150). Hospitalization ranged from 2 to 8 days (median 3). No complications occurred during a 30-day postoperative period. Dysphagia was relieved in 12/14 patients (86%). Heartburn was present postoperatively in 2/14 patients (14%). Manometry showed a significant decrease in median lower oesophageal sphincter (LOS) pressure from 2.9 preoperatively to 1 kPa postoperatively (P = 0.008). Robot-assisted laparoscopic Heller myotomy was demonstrated to be safe and effective in reducing basal LOS pressure and dysphagia. The results of this study clearly support the feasibility of the use of this system in performing a delicate laparoscopic surgical procedure. The use of a robotic system was experienced as being highly supportive in manipulation and visualization by the surgical team involved.

Entities:  

Mesh:

Year:  2004        PMID: 15696842     DOI: 10.1080/00855920410010924

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  8 in total

Review 1.  Robotic-assisted Heller myotomy: a modern technique and review of outcomes.

Authors:  Cheguevara Afaneh; Brendan Finnerty; Jonathan S Abelson; Rasa Zarnegar
Journal:  J Robot Surg       Date:  2015-03-21

2.  Initial experience from a large referral center with robotic-assisted Ivor Lewis esophagogastrectomy for oncologic purposes.

Authors:  Sebastian G de la Fuente; Jill Weber; Sarah E Hoffe; Ravi Shridhar; Richard Karl; Kenneth L Meredith
Journal:  Surg Endosc       Date:  2013-04-03       Impact factor: 4.584

3.  Robot-assisted laparoscopic cardiomyotomy.

Authors:  Heinz F Wykypiel; Johannes Bodner; Florian Augustin; Oliver Renz; Elisabeth Hoeller; Thomas Schmid
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

4.  Robotic heller myotomy and Dor fundoplication for achalasia in a woman with morbid obesity.

Authors:  Abdulkadir Bedirli; Ibrahim Dogan; Ramazan Kozan
Journal:  J Robot Surg       Date:  2012-06-17

5.  Surgical treatment of gastroesophageal reflux disease and upside-down stomach using the Da Vinci robotic system. A prospective study.

Authors:  Jens Hartmann; Christoph A Jacobi; Charalambos Menenakos; Mahmoud Ismail; Chris Braumann
Journal:  J Gastrointest Surg       Date:  2007-11-20       Impact factor: 3.452

6.  Defining the learning curve for robotic-assisted esophagogastrectomy.

Authors:  Jonathan M Hernandez; Francesca Dimou; Jill Weber; Khaldoun Almhanna; Sarah Hoffe; Ravi Shridhar; Richard Karl; Kenneth Meredith
Journal:  J Gastrointest Surg       Date:  2013-05-21       Impact factor: 3.452

Review 7.  Esophageal surgery in minimally invasive era.

Authors:  Lapo Bencini; Luca Moraldi; Ilenia Bartolini; Andrea Coratti
Journal:  World J Gastrointest Surg       Date:  2016-01-27

Review 8.  Telerobotic gastrointestinal surgery: phase 2--safety and efficacy.

Authors:  G H Ballantyne
Journal:  Surg Endosc       Date:  2007-02-08       Impact factor: 3.453

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.